Arkolith/Insider Trading/CRSP/Form 4

Prasad Raju

Chief Financial OfficerCRISPR Therapeutics AG (CRSP) · full profile →Form 4 · filed Mar 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$173K
Net Open-Market Flow
-$173K
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 23, 2026Sell(S)4K$46.78$173K16K
Mar 20, 2026Option exercise(M)6K——19K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 20, 2026Option exercise(M)6K——13K
Mar 20, 2026Grant(A)38K—$038K
Mar 20, 2026Grant(A)28K—$028K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-122268) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML